DNA-PK inhibitor reduces cell viability on colorectal cancer

The aim of the present study was to investigate the anti-colorectal cancer effect of the DNA-PK inhibitor NU7441, which inhibits DNA-DSB repair by blocking the NHEJ pathway, in the HCT116 cell line.